Related Experiment Video
Updated: May 30, 2025
09:32
Resolving Water, Proteins, and Lipids from In Vivo Confocal Raman Spectra of Stratum Corneum through a Chemometric Approach
Published on: September 26, 2019
7.1K
Dermatologists' knowledge, attitudes, and practices regarding omalizumab therapy for chronic urticaria
Shaofang Wu1, Xin Ye1, Xinyang Liu1
1Department of dermatology, Lishui Central Hospital, Lishui, 323000, China.
Archives of Dermatological Research
|January 28, 2025
Summary
Dermatologists show gaps in knowledge regarding omalizumab therapy for chronic urticaria, despite positive attitudes and practices. Targeted education is crucial to improve patient care and outcomes for this condition.
Area of Science:
- Dermatology
- Pharmacology
- Clinical Practice
Background:
- Chronic urticaria is a challenging condition often requiring advanced therapies.
- Omalizumab has emerged as a significant treatment option for chronic spontaneous urticaria.
- Understanding physician perspectives is key to optimizing treatment protocols.
Purpose of the Study:
- To assess dermatologists' knowledge, attitudes, and practices (KAP) regarding omalizumab therapy for chronic urticaria.
- To identify factors influencing the adoption of omalizumab in clinical practice.
- To inform educational strategies for healthcare providers.
Main Methods:
- A cross-sectional study was conducted using a self-administered KAP questionnaire among dermatologists in China.
- Data from 354 valid questionnaires were analyzed.
- Statistical methods included Wilcoxon-Mann-Whitney tests, Kruskal-Wallis ANOVA, and multivariable logistic regression.
Main Results:
- Dermatologists exhibited a mean knowledge score of 5.71/9, indicating areas for improvement.
- Mean attitude and practice scores were 21.39/25 and 19.84/25, respectively, suggesting generally positive outlooks.
- Higher attitude scores, male gender, and awareness of omalizumab were significantly associated with proactive practice.
Conclusions:
- Dermatologists possess positive attitudes and proactive practices but demonstrate insufficient knowledge regarding omalizumab for chronic urticaria.
- A significant knowledge gap necessitates targeted educational interventions.
- Enhancing understanding of omalizumab therapy can lead to improved patient management and outcomes.
Related Concept Videos
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
234
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
234
01:30Hypersensitivities
491
Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
491
01:19Antiasthma Drugs: Leukotriene Modifiers
239
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
239
01:26Peptic Ulcer Disease IV: Management
66
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
66